Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Issues Earnings Results

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) posted its earnings results on Tuesday. The company reported $0.07 earnings per share for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.10), Zacks reports. Bayer Aktiengesellschaft had a positive return on equity of 16.46% and a negative net margin of 2.02%. The company had revenue of $10.96 billion for the quarter. Bayer Aktiengesellschaft updated its FY 2024 guidance to 5.610-6.045 EPS.

Bayer Aktiengesellschaft Price Performance

OTCMKTS:BAYRY opened at $5.41 on Friday. The company has a quick ratio of 0.86, a current ratio of 1.27 and a debt-to-equity ratio of 1.04. The firm’s fifty day moving average is $7.39 and its 200-day moving average is $7.42. Bayer Aktiengesellschaft has a 52 week low of $5.33 and a 52 week high of $11.33.

Wall Street Analyst Weigh In

Separately, Bank of America raised Bayer Aktiengesellschaft from an “underperform” rating to a “neutral” rating in a research note on Friday, September 6th. One analyst has rated the stock with a sell rating and seven have given a hold rating to the company’s stock. According to data from MarketBeat.com, Bayer Aktiengesellschaft has a consensus rating of “Hold”.

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.